Ubiquitin System: The Next Class of Drug Targets?
A Complex Role in Cellular Process & Growing Tool Set to Elucidate It
Bispecific Antibodies Close in on Cancer
Plotting Molecular Pincer Movements, Denying Cancer Room to Maneuver
Resolving Nonspecific Binding, Regeneration and Other Problems
Researchers Turn to Cloud Computing as Genomic Sequencing Data Threatens to Overwhelm Traditional IT Systems
Diagnostics Firm CEOs
GEN recently published a list of the top 10 highest-paid CEOs of diagnostics companies. One thing we noticed while compiling the list was that diagnostics CEOs generally don’t get paid as much as their drug discovery and tools/tech counterparts. What are your thoughts on what these company leaders are paid?